Valtteri Kaasinen
MD, PhD, Professor of Neurology
valtteri.kaasinen@utu.fi ORCID identifier: https://orcid.org/0000-0002-3446-7093 |
Clinical Neurology; Movement Disorders; Parkinson's disease; Addictions; Neurotransmitters; Neuroimaging; PET; SPECT; Dopamine System
Movement disorders, neurotransmitters and addictions
Dr. Kaasinen is Professor of Neurology at the University of Turku, and Chief Physician at Neurocenter of Turku University Hospital.
He was appointed as Adjuct Professor of Neurology in 2011, received special competence in medical education in 2016, and was appointed as full Professor of Neurology in 2021.
Dr. Kaasinen is a clinical neurologist and a movement disorder specialist who received his medical degree from the University of Turku in 1996. This was followed by a PhD focusing on brain dopamine PET imaging of Parkinson's disease in 2000. He did his postdoctoral training in 2003-2004 in the University of Groningen, The Netherlands.
Since 2004, he has led a research group that focuses on function brain PET and SPECT neurotransmitter imaging in Parkinson's disease, other movement disorders and behavioral addictions. His group is involved in several project that aim to improve diagnostics and treatment of neurological movement disorders.
Main focus of research is brain function and dysfunction in relation to neurotransmitters, addictions and movement disorders.
Dr. Kaasinen has been involved in curriculum planning and implementation of neurology courses since 2013. He is a personal teacher mentor for medical students and has supervised of several PhD students.
- Incidence of antiepileptic drug use in Parkinson's disease (2025)
- Journal of Parkinson's Disease
(A1 Refereed original research article in a scientific journal) - Incidence of Opioid Use Before and After Parkinson's Disease Diagnosis (2025)
- European Journal of Pain
(A1 Refereed original research article in a scientific journal) - Increased frontal [123I]FP-CIT binding in Parkinson’s disease patients with self-reported REM sleep behavior disorderOvercoming the dopamine-centric model of impulse control disorders in Parkinson’s disease: the role of 5-HT (2025)
- NPJ Parkinson's diseaseBrain
(A1 Refereed original research article in a scientific journal) - Levodopa exposure and nigral neuroinflammation in parkinsonian disorders: A postmortem study of 63 cases (2025)
- Scientific Reports
(A1 Refereed original research article in a scientific journal) - Liikehäiriöiden lääkehoidon periaatteet Parkinsonin taudissa (2025) Parkinson-potilaan hoidon hyvät käytännöt Kaasinen, Valtteri; Keränen, Tapani;
(D2 Article in a professional compilation book) - Management of neuropsychiatric, motor and non-motor symptoms in Parkinson´s disease after long distance air travel: a consensus view (2025)
- Journal of Neural Transmission
(A2 Refereed review article in a scientific journal ) - Nigral Neuroinflammation and Dopaminergic Neurons in Parkinson's Disease and Atypical Parkinsonisms (2025)
- Annals of Neurology
(A1 Refereed original research article in a scientific journal) - (2025)
(B1 Other refereed article (e.g., editorial, letter, comment) in a scientific journal) - Parkinsonin taudin diagnooseista 18 % muuttuu kymmenen vuoden seurannassa (2025)
- Duodecim
(Other publication) - Parkinsonin taudin diagnostiikka (2025) Parkinson-potilaan hoidon hyvät käytännöt Kaasinen, Valtteri
(D2 Article in a professional compilation book)



